I Holland Launched Innovative New Product Developments at ACHEMA
I Holland has launched two innovative new products at ACHEMA, Frankfurt.
Showcasing for the first time was XDF (eXtended Dwell Flat) a novel patented elliptical head form which has been designed to increase dwell time on an existing press without the need for expensive modifications.
Designed to run on standard cams, it can give users higher press speeds with challenging products and formulations. XDF also enhances tablet compaction and cohesion and can increase dwell time by up to 50% over a standard punch head allowing more dwell than a D-type punch on a B-type tool. This increase helps to solve compression problems without upsizing punches or investing in a new press.
Steve Osborn said: I Holland's XDF has been designed to give manufacturers the tool to produce superior quality tablets. It was created to be run on an existing press on standard cams. This is an important benefit of XDF as it saves on capital outlay, whilst at the same time improving and increasing productivity with enhanced tablet production, resulting in a quality tablet.
Exhibiting alongside I Hollands XDF is the new Tool Management System IH-TMS which allows proactive monitoring of tool rotations and tooling inventory and maintenance.
The stand-alone system allows tablet manufacturers to keep a record of tablet quantities by number of tablets, work order or batch information to ensure production is run efficiently. In addition it has the capability to archive tablet and tool images and drawings.
IH-TMS software is the pinnacle in tablet tool management as it can maintain efficient, well-organised and in-depth monitoring of tablet production. It also incorporates an alarm to alert users of any problems including over compression, tooling replacements or if maintenance is required. It has been created for manufacturers to have a complete audit trail on production, which is obviously important in tablet manufacture, adds Andy Dumelow, I Holland's PharmaCare Product Manager.
Available in several languages and with an embedded copy of the Eurostandard Educational Suite, I Hollands IH-TMS Tool Management System, together with the innovative XDF were well received at Achema.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.